University of Alabama at Birmingham/UAB

Birmingham, Alabama 35924

2 studies enrolling now · 30 studies all time

What they study most

Acquired Immunodeficiency Syndrome, Acromegaly, Acute Kidney Injury (AKI), Adjunctive Treatment of Major Depressive Disorder, Advanced Non-Small Cell Lung Cancer, Breast Cancer, Breast Carcinoma, Candidemia, Chronic Cutaneous Lupus Erythematosus, Cirrhosis, Liver, Continuous Renal Replacement Therapy (CRRT), Eating Behavior

Studies at this site

• Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT — Recruiting now
• A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Enrolling by invitation
• A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors — Running, not enrolling
• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus — Running, not enrolling
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer — Running, not enrolling
• Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease — Completed
• A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer — Running, not enrolling
• Pilot Testing a Behavioral Intervention to Incorporate Advances in HIV Prevention for Black Young MSM in Alabama — Completed
• An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia — Completed
• Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma — Stopped early
• Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer — Stopped early
• Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer — Completed
• Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama — Withdrawn before enrolling
• A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) — Completed
• Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early
• HIV Prevention and PrEP Intervention for SGM Adolescents and Parents: "Hey, Friend" — Withdrawn before enrolling
• SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support? — Completed
• Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early
• Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN) — Completed
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults — Completed
• Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus — Stopped early
• Effect of tDCS Montage on Measures of Appetite — Completed
• Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus — Completed
• Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer — Completed
• Improving Energy Balance in Men With Prostate Cancer — Completed
• Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf) — Completed